Business
Wegovy sales soar 27-fold after rival Mounjaro ramps up price in UK
Sales of weight loss jab Wegovy have soared in the UK after the maker of rival drug Mounjaro said it was hiking prices, a supplier has revealed.
Weight loss programme CheqUp said it had experienced a spike in interest from consumers wanting to switch or begin taking the medication.
This resulted in a 27-fold surge – or 2,660 per cent – in Wegovy sales on Wednesday this week, compared with the daily average in the month prior to the pricing news.
Sales of Wegovy’s lowest dose soared by 2,212 per cent, which CheqUp said reflected many people taking the medication for the first time amid heightened awareness and an end-of-summer health focus.
US manufacturer Eli Lilly last week announced the price of Mounjaro was rising by 170 per cent in the UK.
A month’s supply of the highest dose of the drug will rise from £122 to £330 from September.
Eli Lilly’s decision reflected efforts to more closely align prices with its other European markets, and amid political pressure from US President Donald Trump to keep pharmaceutical prices low for Americans.
The NHS is not set to pay the higher price in order to maintain access for people with obesity and type 2 diabetes accessing it through the health service.
Mounjaro is a weekly prescription weight loss injection that works by lowering the appetite and making people feel fuller between meals.
Alternative Wegovy is also self-administered through weekly injections but contains a different active ingredient.
The lowest dose of Wegovy costs £85 per month, and the highest dose is priced at £160.
More than a million people in the UK are estimated to be currently using weight loss medication.
Toby Nicol, chief executive of CheqUp, said: “We now confidently expect Wegovy to become the most popular weight loss treatment in the UK in the very short-term.
“Our sales of Wegovy in the last week since the price rise of Mounjaro was announced have surpassed all expectations.
“The extraordinary growth in Wegovy adoption has been seen across every dose of the medication, from existing Mounjaro patients switching to higher doses of Wegovy right down to new patients starting their weight loss journeys on the lowest dosage for the first time.
“This underlines that this isn’t just switching, it’s new beginnings, with people prioritising their health and exploring treatment options as awareness grows.”
Business
Britain ‘mustn’t cut ourselves off from China trade opportunities’, CBI chief warns
The UK must not “cut ourselves off” from trade opportunities in China despite security and business risks, the head of the Confederation for British Industry has warned.
CBI chief Rain Newton-Smith highlighted that British businesses see increased trade with Chinese firms as an opportunity to drive growth.
Her remarks came as business leaders were questioned by MPs on Parliament’s Business and Trade Select Committee regarding the UK’s economic relationship with China.
Last December, Prime Minister Sir Keir Starmer admitted China poses security threats to the UK but urged for greater business ties.
Ms Newton-Smith, chief executive of one of the UK’s largest business groups, was positive about the Government’s engagement with China.
“You can’t have a growth strategy without a strategy for China,” she said.
“China has the biggest contribution to global growth, is the third largest trading partner, and the world’s largest consumer market.
“The UK is second largest exporter of trade and services.
“We are mindful as all businesses are of security risks but it is really important that we have a strategy towards China.
“This Government has increased the economic engagement with China and including business within this does help us as a country.”
She added: “If we think about the future economy, there is a huge market in China and I think we mustn’t cut ourselves off from some of the opportunities there, even if in some areas there are difficult conversations and negotiations that need to be had.”
Peter Burnett, chief executive of the China-Britain Business Council, told the committee: “There are risks associated with technology advancement, AI, industrial development that they need to assess.
“Increasingly you will find them saying that they need to engage more in China to understand those risks and to develop some of the technologies along some of those risks themselves.”
Business
Trump says he’d be disappointed if Fed pick doesn’t cut rates; Warsh vows to be ‘independent actor’ – The Times of India
US President Donald Trump on Tuesday said he would be disappointed if his nominee for Federal Reserve chair, Kevin Warsh, does not cut interest rates right away after taking office if confirmed by the Senate. Trump, during an interview with CNBC’s “Squawk Box,” also said “we have to find out” about the construction costs of the new Federal Reserve building.Warsh, a former Federal Reserve official and financier, is currently facing Senate confirmation hearings where he has stressed his independence from political pressure.“The president never once asked me to commit to any particular interest rate decision, and nor would I agree to it if he had,” Kevin Warsh said under questioning by the Senate Banking Committee, as quoted by LA Times. “I will be an independent actor if confirmed as chair of the Federal Reserve.”Warsh told lawmakers that fighting inflation would be one of his main priorities if confirmed.“Congress tasked the Fed with the mission to ensure price stability, without excuse or equivocation, argument or anguish,” Warsh said. “Inflation is a choice, and the Fed must take responsibility for it.”The comments come as investors closely watch his confirmation hearing, with inflation remaining at 3.3% annually and global tensions, including the war in Iran pushing up gas prices, adding pressure on the economy. Higher inflation typically leads the Federal Reserve to keep interest rates steady or raise them rather than cut them, as rate changes affect mortgages, auto loans, and business borrowing.Democrats on the Senate Banking Committee accused Warsh of shifting his stance on interest rates over time, supporting higher rates under Democratic presidents and lower rates during Trump’s presidency.Warsh, if confirmed, would take over at a time when inflation pressures make it difficult for the Federal Reserve to cut rates, even as Trump continues to push for lower borrowing costs. Trump has repeatedly urged rate cuts and has long clashed with current Fed chair Jerome Powell over monetary policy. Powell has also been the subject of a Department of Justice criminal probe after refusing Trump’s requests for faster rate cuts. Trump told CNBC that he does not plan to pressure the Justice Department to end that probe.
Business
Air fares soar by nearly a quarter, research shows
The consultancy Teneo says airspace restrictions caused by the conflict have forced airlines to reroute many flights.
Source link
-
Fashion5 days agoFrance’s LVMH Q1 revenue falls 6%, shows resilience amid Iran war
-
Sports1 week agoThe case for Man United’s Fernandes as Premier League’s best
-
Entertainment1 week agoPalace left in shock as Prince William cancels grand ceremony
-
Business1 week agoUK could adopt EU single market rules under new legislation
-
Entertainment6 days agoIs Claude down? Here’s why users are seeing errors
-
Fashion1 week agoEnergy emerges as biggest cost driver in textile margins
-
Business1 week agoDelta Air Lines unveils first new Delta One suite in premium cabin arms race
-
Fashion1 week agoAsia claims largest share of markets on Kearney FDI Confidence Index
